-
公开(公告)号：US11173202B2
公开(公告)日：2021-11-16
申请号：US16372832
申请日：2019-04-02
Applicant: BAYLOR RESEARCH INSTITUTE
Inventor： SangKon Oh , Dapeng Li
IPC: A61K39/145 , A61K47/68 , A61K51/10 , C07K16/28 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435 , C12N5/0784 , C12N7/00 , A61K39/00
Abstract: The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
-
公开(公告)号：US10279030B2
公开(公告)日：2019-05-07
申请号：US15265236
申请日：2016-09-14
Applicant: BAYLOR RESEARCH INSTITUTE
Inventor： SangKon Oh , Dapeng Li
IPC: A61K39/00 , A61K39/395 , A01N63/00 , A61K39/145 , A61K51/10 , C07K16/28 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435 , C12N5/0784 , C12N7/00 , A61K47/68
Abstract: The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
-
Patent Agency Ranking
3.发明申请AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC-ASGPR) 审中-公开通过DENDRITIC CELL ASIALOGLYCOPROTEIN受体（DC-ASGPR）引入抗原呈递细胞的试剂公开(公告)号：US20160375126A1
公开(公告)日：2016-12-29
申请号：US15265236
申请日：2016-09-14
Applicant: BAYLOR RESEARCH INSTITUTE
Inventor： SangKon Oh , Dapeng Li
IPC: A61K39/145 , C12N7/00 , C12N5/0784 , C07K16/28
CPC classification number: A61K39/145 , A61K47/6849 , A61K51/1027 , A61K2039/5154 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435 , C07K16/28 , C07K2317/24 , C07K2317/33 , C07K2317/56 , C07K2317/74 , C07K2317/75 , C07K2317/92 , C12N5/0639 , C12N7/00 , C12N2760/16122 , C12N2760/16134
Abstract: The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
Abstract translation: 本发明包括用于制备和使用可以例如激活DC和其他细胞的抗DC-ASGPR抗体的组合物和方法。
-
4.发明申请AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC-ASGPR) 有权通过DENDRITIC CELL ASIALOGLYCOPROTEIN受体（DC-ASGPR）引入抗原呈递细胞的试剂公开(公告)号：US20140227268A1
公开(公告)日：2014-08-14
申请号：US14254206
申请日：2014-04-16
Applicant: Baylor Research Institute
Inventor： Jacques F. Banchereau , Sangkon Oh , Gerard Zurawski , Sandra Zurawski , Dapeng Li
IPC: C07K16/28 , C07K14/435 , C07K14/37 , C07K14/405 , C07K14/005 , C07K14/195
CPC classification number: A61K39/145 , A61K47/6849 , A61K51/1027 , A61K2039/5154 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435 , C07K16/28 , C07K2317/24 , C07K2317/33 , C07K2317/56 , C07K2317/74 , C07K2317/75 , C07K2317/92 , C12N5/0639 , C12N7/00 , C12N2760/16122 , C12N2760/16134 , Y02A50/472
Abstract: The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
Abstract translation: 本发明包括用于制备和使用可以例如激活DC和其他细胞的抗DC-ASGPR抗体的组合物和方法。
-
公开(公告)号：US09339556B2
公开(公告)日：2016-05-17
申请号：US13927437
申请日：2013-06-26
Applicant: Baylor Research Institute
Inventor： Jacques F. Banchereau , SangKon Oh , Gerard Zurawski , Sandra Zurawski , Dapeng Li
CPC classification number: A61K47/48369 , A61K2039/5154 , A61K2039/55516 , C07K16/28 , C07K2317/92 , C07K2319/01 , C07K2319/33
Abstract: The present invention includes compositions and methods for targeting the LOX-1 receptor on immune cells and uses for the anti-LOX-1 antibodies.
-
公开(公告)号：US12016915B2
公开(公告)日：2024-06-25
申请号：US17454108
申请日：2021-11-09
Applicant: BAYLOR RESEARCH INSTITUTE
Inventor： SangKon Oh , Dapeng Li , Jacques Banchereau , Gerard Zurawski , Sandra Zurawski
IPC: A61K39/145 , A61K39/00 , A61K47/68 , A61K51/10 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435 , C07K16/28 , C12N5/0784 , C12N7/00
CPC classification number: A61K39/145 , A61K47/6849 , A61K51/1027 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435 , C07K16/28 , C12N5/0639 , C12N7/00 , A61K2039/5154 , C07K2317/24 , C07K2317/33 , C07K2317/56 , C07K2317/74 , C07K2317/75 , C07K2317/92 , C12N2760/16122 , C12N2760/16134
Abstract: The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
-
7.发明授权Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) 有权通过树突状细胞脱唾液酸糖蛋白受体（DC-ASGPR）与抗原呈递细胞接触的药剂公开(公告)号：US09453074B2
公开(公告)日：2016-09-27
申请号：US14254206
申请日：2014-04-16
Applicant: Baylor Research Institute
Inventor： Sangkon Oh , Dapeng Li
IPC: A61K39/00 , A61K39/395 , A01N63/00 , C07K16/28 , A61K47/48 , A61K51/10 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435
CPC classification number: A61K39/145 , A61K47/6849 , A61K51/1027 , A61K2039/5154 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435 , C07K16/28 , C07K2317/24 , C07K2317/33 , C07K2317/56 , C07K2317/74 , C07K2317/75 , C07K2317/92 , C12N5/0639 , C12N7/00 , C12N2760/16122 , C12N2760/16134 , Y02A50/472
Abstract: The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
Abstract translation: 本发明包括用于制备和使用可以例如激活DC和其他细胞的抗DC-ASGPR抗体的组合物和方法。
-
-
-
-
-
-
Search Results
7
records
(took 0.013 seconds)
